• Kala Pharmaceuticals outlines its eye-care strategy. US listing anchors investor interest AD HOC NEWS Thu, 09 Jul 2026 11:26:14 GMT
• Kala Pharmaceuticals updates eye disease strategy as biotech sector evolves AD HOC NEWS Tue, 07 Jul 2026 16:20:44 GMT
• Kala Pharmaceuticals outlines dry eye strategy as investors weigh biotech risk AD HOC NEWS Fri, 03 Jul 2026 20:11:06 GMT
• kala pharmaceuticals stock (us4831191000): valuation in focus after recent gains AD HOC NEWS Fri, 12 Jun 2026 07:53:29 GMT
• kala pharmaceuticals stock (us4831191000): ai infrastructure pivot draws fresh attention AD HOC NEWS Thu, 21 May 2026 19:57:38 GMT
• Gilead Renews WHO Partnership to Fight Deadly Kala-Azar Contract Pharma Thu, 21 May 2026 07:00:00 GMT
• kala pharmaceuticals stock (us4831191000): eye-disease specialist updates investors after pipeline s AD HOC NEWS Tue, 19 May 2026 07:00:00 GMT
• kala pharmaceuticals stock (us4831191000): trial setback continues to shape the story AD HOC NEWS Sun, 17 May 2026 07:00:00 GMT
• ysios capital - 2026 investor profile, portfolio, team & investment trends Tracxn Sat, 09 May 2026 07:00:00 GMT
• kala bio cuts share count to 18.6m in 1-for-50 reverse split Stock Titan Thu, 07 May 2026 07:00:00 GMT
• kala bio announces 1-for-50 reverse stock split effective friday Investing.com Thu, 07 May 2026 07:00:00 GMT
• kala bio celebrates trump executive order as game-changer for psychedelic medicine GlobeNewswire Tue, 21 Apr 2026 11:00:00 GMT
• Trump’s psychedelic order adds $50M, lifts Kala client’s drug plans Stock Titan Tue, 21 Apr 2026 07:00:00 GMT
• kala bio (nasdaq:kala) vs. celularity (nasdaq:celu) financial survey Defense World Mon, 06 Apr 2026 06:06:29 GMT
• kala pharmaceuticals inc (27f0.sg) stock price, news, quote & history Yahoo! Finance Canada Fri, 03 Apr 2026 20:47:34 GMT
• kala sec filings - kala pharmaceuticals inc 10-k, 10-q, 8-k forms stocktitan.net Thu, 02 Apr 2026 07:50:35 GMT
• kala bio, inc. (kala) stock price, news, quote and history Yahoo Finance UK Thu, 02 Apr 2026 02:15:41 GMT
• kala bio brings in ai-focused adviser to reassess phase 2 data Stock Titan Wed, 01 Apr 2026 07:00:00 GMT
• KALA BIO Delivers Industry-Leading AI Infrastructure: Bionic Intelligence Research Agent Now Live GlobeNewswire Mon, 30 Mar 2026 07:00:00 GMT
• kala says its private ai research agent is now live for biotech clients Stock Titan Mon, 30 Mar 2026 07:00:00 GMT
• exclusive: penny stock kala bio transitions to revenue model with ai platform launch - kala bio (nasdaq:k Benzinga Mon, 30 Mar 2026 07:00:00 GMT
• kala pharmaceuticals stock faces uncertainty after delisting and liquidation plan in biotech sector AD HOC NEWS Wed, 25 Mar 2026 07:00:00 GMT
• if you invested $1,000 in kala pharmaceuticals inc (kala) Stock Titan Sun, 22 Mar 2026 07:59:15 GMT
• kala bio (kala) projected to post quarterly earnings on thursday MarketBeat Thu, 19 Mar 2026 07:00:00 GMT
• form 144: restricted stock sale notice — kala pharmaceuticals (nasdaq: kala) Stock Titan Thu, 12 Mar 2026 07:00:00 GMT
• $180B AI healthcare play: KALA BIO pivots with first agent Stock Titan Wed, 11 Mar 2026 07:00:00 GMT
• Kala Bio Launches a Revolution for Biotech- First AI Agent GlobeNewswire Wed, 11 Mar 2026 07:00:00 GMT
• kala bio (kala) stock jumps 70% after pivoting to ai with ‘palantir for biotech’ vision MEXC Wed, 11 Mar 2026 07:00:00 GMT
• Kala Bio Stock Just Plunged 89% Today – Here’s What Happened Stocktwits Thu, 05 Mar 2026 08:00:00 GMT
• $167 billion pharma r&d market largely untapped by ai creates major growth runway for kala bios data-sovereign ai strategy: n a s ... PRLog Thu, 05 Mar 2026 08:00:00 GMT
• kala bio stock soars 22% after hours as emergency financing deal averts asset seizure after eye disease drug trial collapse Stocktwits Thu, 05 Mar 2026 08:00:00 GMT
• biotech data stays in-house as kala bio bets on on-prem ai for drug r&d Stock Titan Wed, 04 Mar 2026 08:00:00 GMT
• kala bio (nasdaq: kala) signs exclusive researgency ai license and $55m younet option Stock Titan Wed, 04 Mar 2026 08:00:00 GMT
• what's going on with kala bio stock wednesday? - kala bio (nasdaq:kala) Benzinga Wed, 04 Mar 2026 08:00:00 GMT
• kala bio eyes pharma r&d spend with secure ai licensing model Bitget Wed, 04 Mar 2026 08:00:00 GMT
• kala financials: income statement, balance sheet & cash flow Stock Titan Tue, 03 Mar 2026 16:53:42 GMT
• kala financials: income statement, balance sheet & cash flow Stock Titan Tue, 24 Feb 2026 16:58:42 GMT
• kala pharmaceuticals: can this penny biotech survive 2025? AD HOC NEWS Fri, 20 Feb 2026 08:00:00 GMT
• director david lazar resigns from kala bio (nasdaq: kala) board Stock Titan Fri, 20 Feb 2026 08:00:00 GMT
• KALA BIO (KALA) names director Avi Minkowitz CEO and CFO as David Lazar steps down Stock Titan Thu, 05 Feb 2026 08:00:00 GMT
• kala bio enters securities purchase agreement with david lazar, names him ceo MSN Tue, 03 Feb 2026 03:22:22 GMT
• kala bio settles $10.6 million debt with oxford finance by investing.com Investing.com Australia Tue, 06 Jan 2026 08:00:00 GMT
• kala pharmaceuticals stock soars after settling $10.6m debt with oxford finance Investing.com Australia Tue, 06 Jan 2026 08:00:00 GMT
• kala pharmaceuticals stock soars after settling $10.6m debt with oxford finance Investing.com Mon, 05 Jan 2026 08:00:00 GMT
• kala bio settles $10.6 million debt with oxford finance Investing.com Mon, 05 Jan 2026 08:00:00 GMT
• how a $2 million payment wiped out $10.6 million in company debt Stock Titan Mon, 05 Jan 2026 08:00:00 GMT
• kala bio directors plan conditional resignations tied to vote TipRanks Mon, 29 Dec 2025 22:19:00 GMT
• why did indaptus therapeutics surge 64% in after-hours trading? Sahm Wed, 24 Dec 2025 03:11:15 GMT
• kala pharmaceuticals stock falls after $10 million share offering by investing.com Investing.com India Sat, 06 Dec 2025 08:00:00 GMT
• Kala Pharmaceuticals stock falls after $10 million share offering Investing.com Fri, 05 Dec 2025 08:00:00 GMT
• kala bio closes $10 million registered direct offering Investing.com Fri, 05 Dec 2025 08:00:00 GMT
• kala bio (nasdaq: kala) completes $10 million offering of 10,000,000 shares to repay debt Stock Titan Fri, 05 Dec 2025 08:00:00 GMT
• kala bio announces closing of $10 million registered direct GlobeNewswire Fri, 05 Dec 2025 08:00:00 GMT
• kala bio announces $10 million registered direct offering of common stock priced at-the-market under nasdaq rules Sahm Thu, 04 Dec 2025 15:45:00 GMT
• kala bio raises $10 million in registered direct offering Investing.com Thu, 04 Dec 2025 08:00:00 GMT
• kala bio (nasdaq: kala) prices $10m registered direct sale of 10m shares at $1.00 Stock Titan Thu, 04 Dec 2025 08:00:00 GMT
• kala bio enters securities purchase agreement with david lazar, names him ceo MSN Wed, 03 Dec 2025 19:15:23 GMT
• kala bio (nasdaq: kala) inks $6m securities deal, appoints david lazar ceo and chair Stock Titan Mon, 01 Dec 2025 08:00:00 GMT
• ncb issues non-bailable warrants against digital vision owners in rs 600-crore drug diversion racket The Tribune Sat, 29 Nov 2025 08:00:00 GMT
• kala bio stock soars 22% after hours as emergency financing deal averts asset seizure after eye disease drug trial collapse Stocktwits Wed, 26 Nov 2025 05:41:39 GMT
• kala bio stock soars 22% after hours as emergency financing deal averts asset seizure after eye disease drug trial collapse Stocktwits Tue, 25 Nov 2025 08:00:00 GMT
• kala pharmaceuticals faces financial and operational challenges TipRanks Thu, 20 Nov 2025 03:56:35 GMT
• kala pharmaceuticals faces financial and operational challenges TipRanks Wed, 19 Nov 2025 08:00:00 GMT
• lifesci capital reaffirms their buy rating on centessa pharmaceuticals (cnta) The Globe and Mail Fri, 14 Nov 2025 08:00:00 GMT
• kala pharmaceuticals faces nasdaq compliance challenge The Globe and Mail Thu, 13 Nov 2025 08:00:00 GMT
• kala pharmaceuticals secures convertible loan amid challenges TipRanks Mon, 10 Nov 2025 08:00:00 GMT
• kala pharmaceuticals secures convertible loan amid challenges TipRanks Sun, 09 Nov 2025 08:00:00 GMT
• rules not followed, kala amb drug firm ordered to stop manufacturing The Tribune Thu, 06 Nov 2025 08:00:00 GMT
• rules not followed, kala amb drug firm ordered to stop manufacturing Tribune India Wed, 05 Nov 2025 21:30:16 GMT
• Partner in Kala Amb-based pharma firm arrested by NCB The Indian Express Tue, 04 Nov 2025 08:00:00 GMT
• Eye disease biotech Kala Bio collapses after failed drug trial, lender takes control The Business Journals Tue, 21 Oct 2025 07:00:00 GMT
• hda 2025 traceability seminar: fda emphasizes readiness over perfection Pharmaceutical Commerce Mon, 20 Oct 2025 07:00:00 GMT
• kala pharmaceuticals faces foreclosure and leadership changes TipRanks Mon, 20 Oct 2025 07:00:00 GMT
• kala sec filings - kala pharmaceuticals inc 10-k, 10-q, 8-k forms Stock Titan Fri, 03 Oct 2025 07:00:00 GMT
• kala pharmaceuticals reports mixed late-stage study data for kpi-121 in dry eye disease; shares drop FirstWord Pharma Fri, 03 Oct 2025 04:36:54 GMT
• kala pharmaceuticals faces default notice from oxford finance TipRanks Wed, 01 Oct 2025 07:00:00 GMT
• kala bio faces diminishing options after eye drug failure Citeline News & Insights Tue, 30 Sep 2025 07:00:00 GMT
• kala bio scraps development of eye disease drug after trial failure ETPharma.com Tue, 30 Sep 2025 07:00:00 GMT
• kala bio halts eye drug development after phase 2b trial failure Medical Dialogues Tue, 30 Sep 2025 07:00:00 GMT
• u.s. shares higher at close of trade; dow jones industrial average up 0.15% Investing.com UK Mon, 29 Sep 2025 21:25:44 GMT
• united states shares higher at close of trade; dow jones industrial average up 0.15% Investing.com India Mon, 29 Sep 2025 20:43:16 GMT
• u.s. stocks higher at close of trade; dow jones industrial average up 0.15% Investing.com Mon, 29 Sep 2025 20:30:00 GMT
• kala bio stock just plunged 89% today – here’s what happened Stocktwits Mon, 29 Sep 2025 14:03:45 GMT
• kala to cease development of kpi-012, evaluate strategic options TipRanks Mon, 29 Sep 2025 13:56:13 GMT
• Kala Bio stock plunges after failed Phase 2b trial for eye treatment Investing.com Mon, 29 Sep 2025 07:00:00 GMT
• Arlington biotech slashes workforce in half after trial failure The Business Journals Mon, 29 Sep 2025 07:00:00 GMT
• enanta pharmaceuticals stock rises 58% – here’s an important update Stocktwits Mon, 29 Sep 2025 07:00:00 GMT
• kala bio announces topline results from chase phase 2b clinical trial evaluating kpi-012 for the treatment of persistent corneal e... Yahoo Finance Mon, 29 Sep 2025 07:00:00 GMT
• kala pharmaceuticals halts kpi-012 development after trial failure TipRanks Mon, 29 Sep 2025 07:00:00 GMT
• moonlake stock climbs after-hours: retail traders shrug off record plunge, more wall street downgrades Stocktwits Mon, 29 Sep 2025 07:00:00 GMT
• kala stock falls sharply after kpi-012 clinical trial disappointment GuruFocus Mon, 29 Sep 2025 07:00:00 GMT
• big moves in pharma: leadership shuffles and billion-dollar deals Devdiscourse Mon, 29 Sep 2025 07:00:00 GMT
• kala bio plunges 92% after phase 2 failure of eye condition drug Seeking Alpha Mon, 29 Sep 2025 07:00:00 GMT
• kala pharmaceuticals downgraded to market perform at lifesci capital TipRanks Mon, 29 Sep 2025 07:00:00 GMT
• kala pharmaceuticals halts kpi-012 development after trial failure TipRanks Sun, 28 Sep 2025 07:00:00 GMT
• strategic positioning and trial design propel kala pharmaceuticals to ‘buy’ rating TipRanks Thu, 18 Sep 2025 07:00:00 GMT
• kala pharmaceuticals price target raised to $35 from $12 at h.c. wainwright TipRanks Wed, 17 Sep 2025 07:00:00 GMT
• analysts offer insights on healthcare companies: kala pharmaceuticals (kala) and milestone pharmaceuticals (mist) The Globe and Mail Tue, 16 Sep 2025 09:50:00 GMT
• kala pharmaceuticals price target raised to $33 from $15 at oppenheimer TipRanks Thu, 11 Sep 2025 07:00:00 GMT
• persistent corneal epithelial defects pipeline analysis, 2025 | pceds clinical trials | eyevance, amber ophthalmics, kala pharmace... The Globe and Mail Mon, 08 Sep 2025 07:00:00 GMT
• kala pharmaceuticals initiated with an outperform at mizuho TipRanks Mon, 08 Sep 2025 07:00:00 GMT
• Individual investors are KALA BIO, Inc.'s (NASDAQ:KALA) biggest owners and were rewarded after market cap rose by US$28m last week... simplywall.st Fri, 05 Sep 2025 07:00:00 GMT
• rare eye disease biotech kala bio to present latest developments at h.c. wainwright conference Stock Titan Wed, 03 Sep 2025 07:00:00 GMT
• kala bio appoints todd bazemore as president, chief executive officer and director Stock Titan Tue, 02 Sep 2025 12:00:00 GMT
• rare disease expert todd bazemore takes helm at kala bio ahead of crucial phase 2b trial results Stock Titan Tue, 02 Sep 2025 07:00:00 GMT
• wall street analysts are bullish on top healthcare picks The Globe and Mail Thu, 14 Aug 2025 07:00:00 GMT
• optimistic buy rating for kala pharmaceuticals driven by kpi-012 trial prospects and financial viability TipRanks Wed, 13 Aug 2025 07:00:00 GMT
• kala bio reports q2 2025 earnings: eps -$1.82, revenue unavailable; focus on advancing kpi-012 for rare eye diseases. AInvest Mon, 11 Aug 2025 01:12:03 GMT
• kala bio reports q2 2025 earnings: eps -$1.82, revenue unavailable; focus on advancing kpi-012 for rare eye diseases. AInvest Sun, 10 Aug 2025 07:00:00 GMT
• suresh kashyap raised issue of paonta kala amb railway line which will benefit pharma industry himachalheadlines.com Thu, 31 Jul 2025 07:00:00 GMT
• shimla mp suresh kashyap seeks rail line to connect pharma hub in paonta sahib and kala amb The Times of India Wed, 30 Jul 2025 07:00:00 GMT
• acute ocular pain treatment market forecast to surge by 2034 as key pharma players drive therapeutic innovation delveinsight Menafn Tue, 29 Jul 2025 11:12:27 GMT
• blepharitis drugs market hits new high | major giants allergan (abbvie), novartis, bausch health newstrail.com Sat, 26 Jul 2025 15:57:34 GMT
Kala Pharmaceuticals, Inc(NASDAQ:KALA) 
Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary nanoparticle-based Mucus Penetrating Particles (MPP) technology for the treatment of eye diseases. The company's product candidates include EYSUVIS...
Website: http://www.kalarx.com
Founded: 2009
Full Time Employees: 136
Sector: Healthcare
Industry: Biotechnology